All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

FDA Panel Unanimously Supports New Lymphoma Treatment

July 15th 2011

ODAC unanimously recommended accelerated approval for brentuximab vedotin (Adcetris) in 2 types of lymphoma.

Patients With Bladder Cancer Not Getting Recommended Care

July 14th 2011

Study results reveal that only a small fraction of patients with high-grade, noninvasive bladder cancer receive the appropriate treatment.

BOLERO-2 Halted After Positive Interim Analysis

July 13th 2011

A phase III study of Afinitor (everolimus) tablets combined with exemestane in women with breast cancer revealed that the regime significantly extended PFS.

Study Shows Estrogen Not the Only Hormone Feeding Tumors in Breast Cancer

July 13th 2011

Although researchers know that estrogen plays a role in most cases of breast cancer, they don't fully understand how.

FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain

July 12th 2011

FDA approvad Lazanda (fentanyl) nasal spray for the management of breakthrough pain in adult cancer patients.

Afinitor Halves SEGA Tumor Size in Patients With Tuberous Sclerosis

July 11th 2011

In the phase III EXIST-1 trial, Afinitor reduced the size of SEGAs-benign brain tumors associated with TSC-by ≥50% in one-third of patients.

Amgen Seeks to Expand Xgeva's FDA Approval

July 11th 2011

A pivotal phase III study found that men with CRPC experienced prolonged bone metastasis–free survival with Xgeva versus placebo.

New Cigarette Warnings

July 11th 2011

Will graphic images and stronger warnings decrease cigarette smoking?

New Crizotinib Results Show Positive Outcomes

July 8th 2011

Crizotinib demonstrated marked antitumor activity among patients with advanced ALK-positive non–small cell lung cancer.

Colon Cancer Screening Saves Lives Yet Screening Rates Remain Below Standard

July 7th 2011

Almost 1 in 3 adults in the United States do not get screened regularly.

NCI Examines Cediranib to Fight Metastatic Prostate Cancer

July 7th 2011

Prostate cancer metastases, or cancer growing outside the prostate glands, can occur in any organ but is seen most frequently in the bone.

Simple Asana Practice

July 7th 2011

Simple asana that you can practice on your own at any time.

Celecoxib: Effective in Former Smokers as Lung Cancer Chemoprevention

July 6th 2011

A recent study revealed that celecoxib (Celebrex), a COX-2 inhibitor, might be a successful lung cancer chemoprevention in former smokers.

Beginning a Yoga Asana Practice

July 6th 2011

Asana, the third limb of yoga, is the physical aspect of yoga practice.

Childhood Cancer Survivors at Increased Risk of Developing Subsequent Cancers

July 5th 2011

A study published last week has identified new cancer risks for childhood cancer survivors.

Nurses Love Their Jobs, Right?

July 5th 2011

A recent survey found that 24% of RNs are dissatisfied and looking for new jobs.

Comorbid Conditions Threaten Breast Cancer Survivors

July 1st 2011

Breast cancer survivors age 66 and older are more likely to die of cardiovascular disease (CVD) than they are of the cancer itself.

Screening With Low-Dose CT Scan Reduces Deaths From Lung Cancer

June 30th 2011

Patients screened with low-dose helical computed tomography (CT) reduced their risk of dying of lung cancer by 20% compared with chest x-ray.

ODAC Upholds Vote to Revoke Avastin's Breast Cancer Indication

June 29th 2011

An FDA advisory committee unanimously recommended Wednesday that the agency withdraw the breast cancer indication for Avastin.

Yoga Poses

June 28th 2011

Hatha yoga focuses on a physical practice.

x